PAR paradigm biopharmaceuticals limited..

A little taste before mains?, page-7

  1. 615 Posts.
    lightbulb Created with Sketch. 150
    Hello everybody, not sure if it has been mentioned but there is an excellent research report written by MST dated June 30.
    Key points:
    They value PAR at $888mn.
    Believe MPS will get licensed - mention Biomarin.
    BUT predict KOA (if/when approved) will be launched under a sales/distribution model to capture higher margin.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
0.010(2.44%)
Mkt cap ! $166.9M
Open High Low Value Volume
40.0¢ 42.0¢ 40.0¢ $168.2K 411.3K

Buyers (Bids)

No. Vol. Price($)
1 3500 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 50665 2
View Market Depth
Last trade - 16.11pm 18/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.